Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong‐Ho Cha(The University of Texas MD Anderson Cancer Center), Wenhao Yang(The University of Texas MD Anderson Cancer Center), Weiya Xia(The University of Texas MD Anderson Cancer Center), Yongkun Wei(The University of Texas MD Anderson Cancer Center), Li-Chuan Chan(The University of Texas MD Anderson Cancer Center), Seung‐Oe Lim(The University of Texas MD Anderson Cancer Center), Chia-Wei Li(The University of Texas MD Anderson Cancer Center), Tae‐Wan Kim(The University of Texas MD Anderson Cancer Center), Shih-Shin Chang(The University of Texas MD Anderson Cancer Center), Heng‐Huan Lee(The University of Texas MD Anderson Cancer Center), Jennifer L. Hsu(The University of Texas MD Anderson Cancer Center), Hung-Ling Wang(China Medical University), Chu‐Wei Kuo(Institute of Biological Chemistry, Academia Sinica), Wei‐Chao Chang(China Medical University), Sirwan Hadad(University of Sheffield), Colin A. Purdie(Ninewells Hospital), Aaron McCoy(The University of Texas MD Anderson Cancer Center), Shirong Cai(The University of Texas MD Anderson Cancer Center), Yizheng Tu(The University of Texas MD Anderson Cancer Center), Jennifer K. Litton(The University of Texas MD Anderson Cancer Center), Elizabeth A. Mittendorf(The University of Texas MD Anderson Cancer Center), Stacy Moulder(The University of Texas MD Anderson Cancer Center), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Alastair M. Thompson(The University of Texas MD Anderson Cancer Center), Helen Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), Chung‐Hsuan Chen(Genomics Research Center, Academia Sinica), Kay‐Hooi Khoo(Institute of Biological Chemistry, Academia Sinica), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center)
Molecular Cell
August 1, 2018
Cited by 756

Abstract


Related Papers

No related papers found

Powered by citation graph analysis